ONGC shares in focus after petrochemical arm exits from Dahej SEZ, eyes local market
Shares of ONGC will be in focus after its subsidiary OPaL shifts from export focus to the domestic market by exiting SEZ ...
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million or over Rs 3,000 crore
Checkpoint is a commercial-stage company that develops novel treatments for patients with solid tumor cancers, and the acquisition includes UNLOXCYT, an FDA-approved treatment for advanced skin cancer ...